Day: January 7, 2023

VANCOUVER, British Columbia and AUSTIN, Texas, Jan. 06, 2023 (GLOBE NEWSWIRE) — Inspire Semiconductor Holdings Inc. (TSXV: INSP) (“InspireSemi” or the “Company”), a chip design company that has built a technology foundation to deliver revolutionary performance, today announced that it has closed the first tranche of its previously announced non-brokered private placement (the “Financing”) of units (the “Units”) raising approximately 1/3 of the anticipated gross proceeds as previously announced by the Company in its press release dated December 7, 2022 (the “Financing Press Release”). As previously disclosed, each Unit being comprised of (i) an unsecured convertible debenture in a principal amount of C$1,000 and (ii) 52 proportionate voting share purchase warrants. The Company expects to close additional tranches of the Financing...

ROCKVILLE, Md., Jan. 06, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced the pricing of a public offering of an aggregate of 2,586,207 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 warrants to purchase up to 2,586,207 shares of common stock and Series A-2 warrants to purchase 2,586,207 shares of common stock, at a combined public offering price of $2.90 per share (or pre-funded warrant in lieu thereof) and accompanying warrants. The Series A-1 warrants will have an exercise price of $2.65 per share, will be exercisable immediately upon issuance and will expire five years from the date of issuance, and the Series A-2 warrants...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 06, 2023 (GLOBE NEWSWIRE) — Prospect Park Capital ‎ Corp. ‎‎(CSE:PPK) (the “Company”) is pleased to announce a non-brokered private placement (the “Offering”) of common shares (each, a “Common Share”) and the closing of the first tranche of the Offering. Offering The Company is pleased to announce the Offering of up to 30,000,000 Common Shares at a price of $0.01 per share for total gross proceeds of up to $300,000. The Company intends to use the net proceeds of the Offering for operational, general and administrative purposes. Closing of the Offering is expected to occur in multiple tranches and the Company expects to complete subsequent tranches of the Private Placement on or before February 12,...

VANCOUVER, British Columbia, Jan. 06, 2023 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon” or the “Company”) announces that it has granted 1,055,000 stock options in accordance with the Company’s Equity Incentive Plan (the “Plan”). The Company has granted stock options to certain employees of Rubicon to acquire an aggregate of 1,055,000 common shares at $0.90 per share, for a period of five years. The stock options vest annually in equal tranches over three years. ABOUT RUBICON ORGANICS INC. Rubicon Organics Inc. is the global brand leader in premium organic cannabis products. The Company is vertically integrated through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer. Rubicon Organics is focused on achieving industry leading profitability through its premium cannabis flower,...

TORONTO, Jan. 06, 2023 (GLOBE NEWSWIRE) — Labrador Uranium Inc. (“LUR”, “Labrador Uranium”, or the “Company”) (CSE: LUR, OTCQB: LURAF, FRA: EI1) announces that it has granted stock options to purchase an aggregate of 2,650,000 common shares of the Company to management, directors, and consultants of the Company pursuant to the terms of the Company’s share-based incentive plan. The options are exercisable at a price of $0.35 per common share. All Options expire on the date that is five years from the date of grant and vest and become exercisable as to one-third on the date of grant, with the remaining Options vesting in equal parts on the one-year and two-year anniversary of the date of grant. The options are subject to approval of the Canadian Securities Exchange. About Labrador Uranium Inc. Labrador Uranium is engaged in...

EMERYVILLE, Calif., Jan. 06, 2023 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”), the Biotech Royalty Aggregator, today announced the Company has granted Owen Hughes, the Company’s newly appointed Executive Chairman, two separate non-qualified stock options to purchase: (i) 100,000 shares of the Company’s common stock at an exercise price of $18.66 per share (the “First Hughes Inducement Award”) and (ii) 75,000 shares of the Company’s common stock at an exercise price of $30.00 per share (the “Second Hughes Inducement Award” and together with the First Hughes Inducement Award, the “Hughes Inducement Awards”) on January 3, 2023.  The First Hughes Inducement Award will vest in a series of four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.  The Second...